- Home
- RPTX vs VIGL Comparison
RPTX vs VIGL Comparison
Compare RPTX & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- VIGL
- Stock Information
- Founded
- RPTX 2016
- VIGL 2020
- Country
- RPTX Canada
- VIGL United States
- Employees
- RPTX N/A
- VIGL N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- RPTX Health Care
- VIGL Health Care
- Exchange
- RPTX Nasdaq
- VIGL Nasdaq
- Market Cap
- RPTX 63.9M
- VIGL 134.9M
- IPO Year
- RPTX 2020
- VIGL 2022
- Fundamental
- Price
- RPTX $1.54
- VIGL $8.05
- Analyst Decision
- RPTX Strong Buy
- VIGL Buy
- Analyst Count
- RPTX 3
- VIGL 7
- Target Price
- RPTX $4.50
- VIGL $8.00
- AVG Volume (30 Days)
- RPTX 95.8K
- VIGL 1.1M
- Earning Date
- RPTX 08-05-2025
- VIGL 08-12-2025
- Dividend Yield
- RPTX N/A
- VIGL N/A
- EPS Growth
- RPTX N/A
- VIGL N/A
- EPS
- RPTX N/A
- VIGL N/A
- Revenue
- RPTX $1,073,000.00
- VIGL N/A
- Revenue This Year
- RPTX N/A
- VIGL N/A
- Revenue Next Year
- RPTX N/A
- VIGL N/A
- P/E Ratio
- RPTX N/A
- VIGL N/A
- Revenue Growth
- RPTX N/A
- VIGL N/A
- 52 Week Low
- RPTX $0.89
- VIGL $1.31
- 52 Week High
- RPTX $4.29
- VIGL $8.06
- Technical
- Relative Strength Index (RSI)
- RPTX 65.29
- VIGL 88.18
- Support Level
- RPTX $1.40
- VIGL $7.86
- Resistance Level
- RPTX $1.59
- VIGL $8.05
- Average True Range (ATR)
- RPTX 0.05
- VIGL 0.02
- MACD
- RPTX 0.01
- VIGL -0.15
- Stochastic Oscillator
- RPTX 81.82
- VIGL 73.15
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.